Volume 13, Issue 2 ( June 2021 2021)                   Iranian Journal of Blood and Cancer 2021, 13(2): 62-64 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bhat R R, Lashkari H, Ramprakash S, Pereira D. Triple Drug Iron Chelation Therapy in Thalassemia Major; A Case Report. Iranian Journal of Blood and Cancer 2021; 13 (2) :62-64
URL: http://ijbc.ir/article-1-1004-en.html
1- Department of Pediatrics, Kasturba Medical College and Manipal Academy of Higher education (MAHE), Mangaluru, India
2- Department of Pediatrics, Kasturba Medical College and Manipal Academy of Higher education (MAHE), Mangaluru, India , harsha.pl@manipal.edu
3- Aster CMI hospital, Bangalore, India
4- Regional advanced pediatric care center, Mangaluru, India
Abstract:   (2398 Views)

Regular packed cell transfusion in patients with thalassemia major leads to iron overload. Chelation therapy is one of the important aspects of thalassemia care as iron overload causes significant cardiac, hepatic, and endocrine dysfunction. We report a case of thalassemia major with severe iron overload causing cardiac and liver dysfunction who benefitted from triple drug chelation therapy. Triple iron chelation therapy in thalassemia major could be suggested in severe iron overload patients.

Full-Text [PDF 396 kb]   (1259 Downloads)    
: Case report | Subject: Pediatric Hematology & Oncology
Received: 2020/05/9 | Accepted: 2021/06/9 | Published: 2021/07/15

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb